$15.96 0.0 0.0%
Last Trade - 01/03/21
| Market Cap | ÂŁ63.1m |
| Enterprise Value | ÂŁ62.1m |
| Revenue | ÂŁn/a |
| Position in Universe | 5141st / 6633 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 119 | ||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Biophytis SA, formerly Institut Biophytis Sas is a France-based company engaged in the healthcare industry. The Company is a biotechnology entity specialized in the development of drug candidates to treat ageing diseases. Its two programs relate to sarcopenia (loss of muscle functionality) and Age Related Macular Degeneration (ARMD). Biophytis SA is engaged in the clinical and regulatory development of its drug candidates, such as Sarconeos (BIO101) and Macuneos (BIO201), simultaneously in the United States and domestic market.
| Last Annual | December 31st, 2019 |
| Last Interim | June 30th, 2020 |
| Incorporated | April 20, 2007 |
| Public Since | July 13, 2015 |
| No. of Shareholders: | n/a |
| No. of Employees: | 21 |
| Sector | Healthcare |
| Industry | Biotechnology & Medical Research |
| Index | Nasdaq Composite , |
| Exchange | NASDAQ Capital Market (Dual Listing) |
| Shares in Issue | 54,834,978 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | 14 avenue de l'Opera, PARIS, 75001, France |
| Web | http://www.biophytis.com/ |
| Phone | +33 1 41836600 |
| Contact | () |
| Auditors | Ernst & Young et Autres |
As of 01/03/21, shares in Biophytis SA are trading at $15.96, giving the company a market capitalisation of ÂŁ63.1m. This share price information is delayed by 15 minutes.
Shares in Biophytis SA are currently trading at $15.96 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Biophytis SA price has moved by % over the past year.
There are no analysts currently covering Biophytis SA.
Biophytis SA is scheduled to issue upcoming financial results on the following dates:
Biophytis SA does not currently pay a dividend.
Biophytis SA does not currently pay a dividend.
Biophytis SA does not currently pay a dividend.
To buy shares in Biophytis SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Biophytis SA are currently trading at $15.96, giving the company a market capitalisation of ÂŁ63.1m.
Here are the trading details for Biophytis SA:
Based on an overall assessment of its quality, value and momentum, Biophytis SA is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Biophytis SA are currently priced at $15.96. At that level they are trading at 89.43% premium to the analyst consensus target price of 0.00.
Analysts covering Biophytis SA currently have a consensus Earnings Per Share (EPS) forecast of -0.22 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biophytis SA. Over the past six months, the relative strength of its shares against the market has been %. At the current price of $15.96, shares in Biophytis SA are trading at 0.25% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Biophytis SA.
Biophytis SA's management team is headed by:
Here are the top five shareholders of Biophytis SA based on the size of their shareholding:
